Rahmans Chambers2020-08-12T17:32:48+06:00The good news on the economic front has started to roll in once again, with the latest being China-based Oryx Biotech's announcement to invest $300 million to set up a plasma fractionation plant in Bangladesh.
The company yesterday inked the tripartite agreement with Summit Technopolis, a...
